FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/10/005155 [Registered on: 30/10/2014] Trial Registered Retrospectively
Last Modified On: 30/10/2014
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   A clinical trial to study and compare the effects of hyaluronidase, dexamethasone and their combination in patients with oral submucous fibrosis 
Scientific Title of Study   A Randomised, Double - blind, Multiple arm Trial to Compare the Efficacy of Submucosal injections of Hyaluronidase, Dexamethasone and Combination of Dexamethasone and Hyaluronidase in the Management of Oral Submucous Fibrosis 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rajitha A V 
Designation  pg student 
Affiliation  govt.dental college,calicut 
Address  PG student, Dept of OMR, Govt Dental college, Calicut
govt dental college,medical college campus,chevayoor,calicut,673008
Kozhikode
KERALA
673008
India 
Phone  9400444492  
Fax  914952356781  
Email  raji_nbr@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Anita Balan 
Designation  professor and head 
Affiliation  govt.dental college,calicut 
Address  Head of the Dept, Dept. of OMR,Govt Dental college, Calicut
govt dental college,medical college campus,chevayoor,calicut,673008
Kozhikode
KERALA
673008
India 
Phone  9447800944  
Fax  914952356781  
Email  anitabalan4@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Anita Balan 
Designation  professor and head 
Affiliation  govt.dental college,calicut 
Address  Head of the Dept, Dept. of OMR,Govt Dental college, Calicut
govt dental college,medical college campus,chevayoor,calicut,673008
Kozhikode
KERALA
673008
India 
Phone  9447800944  
Fax  914952356781  
Email  anitabalan4@yahoo.co.in  
 
Source of Monetary or Material Support  
goverment dental college, kozhikode, kerala 
 
Primary Sponsor  
Name  STATE BOARD OF MEDICAL RESEARCH 
Address  govt dental college,medical college campus, kozhikode 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr RAJITHA AV  OPD,government dental college kozhikode  Room no.9, Department of OMR Government Dental college kozhikode
Kozhikode
KERALA 
9400444492
914952356781
raji_nbr@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee, Govt Dental college, Calicut, Kerala, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Oral submucous fibrosis ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  injection hyaluronidase- HYANIDASE  biweekly submucosal injection of hyaluronidase 1500 I.U diluted with 2 ml of water for injection and 1ml of 2% lignocaine with adrenaline (1:80000)using 27 gauge needle for a period of 5 weeks 
Comparator Agent  INJECTION OF COMBINATION OF DEXAMETHASONE AND HYALURONIDASE  biweekly submucosal injection of combination of dexamethasone 1 ml (4mg/ml)and 1 part of hyaluronidase 1500 I.U diluted with 1 ml of water for injection and 1ml of 2% lignocaine with adrenaline (1:80000)using 27 gauge needle for a period of 5 weeks 
Intervention  injecttion dexatmethasone- DEXONA   biweekly submucosal injection of dexamethasone 2 ml (4mg/ml) with 1ml of 2% lignocaine with adrenaline (1:80000)using 27 gauge needle for a period of 5 weeks 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  Patients clinically diagnosed and histopathologically confirmed as OSF

 
 
ExclusionCriteria 
Details  Patients having severe systemic problems or pregnant ladies,
patients having history of drug allergy or hypersensitivity to hyaluronidase, dexamethasone or lignocaine,
a previous history of treatment for OSF or malignancy arising in OSF or patients unwilling for treatment

 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Centralized 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1.Increase in mouth opening in millimetres.
2.decrease in subjective symptoms a) pain b) burning sensation of buccal mucosa c)tightness of buccal mucosa
all the above changes are acessed using numeric rating scale.d) protrusion of tongue relative to the alveolar ridge is asessed.
3.histopathologic improvements. 
at the start of therapy
2 weeks after final injection
1 month, 2month, three month and 6 month after final injection 
 
Secondary Outcome  
Outcome  TimePoints 
1.Increase in mouth opening in millimetres.
2.decrease in subjective symptoms a) pain b) burning sensation of buccal mucosa c)tightness of buccal mucosa
all the above changes are acessed using numeric rating scale.d) protrusion of tongue relative to the alveolar ridge is acessed.
3.histopathologic improvements. 
after one year 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/04/2011 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Numerous treatment modalities have been advocated for oral submucous fibrosis over years, but it is not yet fully standardized.  Moreover , RCT’s are lacking. This RCT is done to acess a better treatment option. The efficacy of local sub-mucosal injections of hyaluronidase, dexamethasone and their combinations are tested and evaluated for improvements in mouth opening, pain , burning sensation and tongue protrusion. The results are compared and confirmed with subsequent histopathological studies. 
Close